Cleared Traditional

K883540 - OXOID INFECTIOUS MONONUCLEOSIS KIT

K883540 is an FDA 510(k) clearance for OXOID INFECTIOUS MONONUCLEOSIS KIT, manufactured by Unipath , Ltd.. The device is a Class 2 Immunology device with product code KTN cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K883540 · Unipath , Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
62d
Days
Class 2
Risk

K883540 is an FDA 510(k) clearance for the OXOID INFECTIOUS MONONUCLEOSIS KIT. Classified as System, Test, Infectious Mononucleosis (product code KTN), Class II - Special Controls.

Submitted by Unipath , Ltd. (Bedford Mk41 Oqg, GB). The FDA issued a Cleared decision on October 19, 1988 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5640 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Unipath , Ltd. devices

FDA 510(k) Submission Details - K883540

510(k) Number K883540 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 1988
Decision Date October 19, 1988
Days to Decision 62 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 105d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KTN Device Classification - Class 2, Special Controls

Product Code KTN System, Test, Infectious Mononucleosis
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - KTN System, Test, Infectious Mononucleosis

All 42
Devices cleared under the same product code (KTN) and FDA review panel - the closest regulatory comparables to K883540.
V-TREND TARGET IM TEST
K890041 · Texas Immunology, Inc. · Jan 1989
MODIFICATION OF MONO-PLUS(TM)
K883709 · Armkel, LLC · Dec 1988
CARDS(TM) MONO
K884007 · Pacific Biotech, Inc. · Nov 1988
V-TREND IM DRY-SPOT TEST
K880399 · Texas Immunology, Inc. · Feb 1988
DIFFERENTIAL I.M. SCREENING TEST
K873297 · Sclavo, Inc. · Dec 1987
VENTRESCREEN (TM) MONO
K872032 · Ventrex Laboratories, Inc. · Jun 1987